255 related articles for article (PubMed ID: 28410236)
1. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
[TBL] [Abstract][Full Text] [Related]
2. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.
Wang L; Xia ZJ; Huang HQ; Lu Y; Zhang YJ
Int J Hematol; 2012 Nov; 96(5):617-23. PubMed ID: 22983648
[TBL] [Abstract][Full Text] [Related]
5. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
6. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ
Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
[TBL] [Abstract][Full Text] [Related]
8. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
[TBL] [Abstract][Full Text] [Related]
9. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
[TBL] [Abstract][Full Text] [Related]
10. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.
Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B
Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411
[TBL] [Abstract][Full Text] [Related]
12. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
Li ZM; Zhu YJ; Sun J; Xia Y; Huang JJ; Zou BY; Lin TY; Huang HQ; Jiang WQ
Ann Hematol; 2012 Aug; 91(8):1265-70. PubMed ID: 22373550
[TBL] [Abstract][Full Text] [Related]
13. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
[TBL] [Abstract][Full Text] [Related]
14. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Li P; Jiang L; Zhang X; Liu J; Wang H
BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients.
Li K; Wang R; Huang S; Pan X; Chen H; Zhou L; Wei J; Wu C; Zhu X; Liang S; Qu S
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e537-e543. PubMed ID: 30243570
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
18. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.
Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY
Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116
[TBL] [Abstract][Full Text] [Related]
19. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL
EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540
[TBL] [Abstract][Full Text] [Related]
20. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.
Yang Y; Zhang YJ; Zhu Y; Cao JZ; Yuan ZY; Xu LM; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Liu QF; Li YX
Leukemia; 2015 Jul; 29(7):1571-7. PubMed ID: 25697894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]